Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Hemodynamic and Clinical Effects of Natrecor (Nesiritide) Compared With Nitroglycerin Therapy for Symptomatic Decompensated CHF, The VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure

NCT00270374 is registered in ClinicalTrials.gov with Scios, Inc. as lead sponsor.

NCT NCT00270374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00270374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Hemodynamic and Clinical Effects of Natrecor (Nesiritide) Compared With Nitroglycerin Therapy for Symptomatic Decompensated CHF, The VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure
Lead sponsor
Scios, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1999
Completion date
August 31, 2000
Enrollment
498 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure in acute coronary syndrome, symptomatic decompensated congestive heart failure